Tools & Resources
Commissioning for Excellence in Haemophilia
Baxter has developed a website resource that can be used to support commissioners deliver high quality, cost effective, patient-centred care for people with haemophilia.
On the site there are health economic tools and a Budget Impact Model that enables comparison of the impact of on-demand versus prophylactic therapy with FEIBA, Baxter’s inhibitor bypassing agent on drug spend.
There are also helpful resources to help you understand the challenges of managing haemophilia, particularly patients with inhibitors.
To visit the site click here